Clinical Trial Update: Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Given With Or Without Food. [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study of an orally disintegrating tablet of sildenafil, with and without food, completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Erectile Dysfunction | Phase 1 | Status: COMPLETED | Results posted: 2012-02-08